Livento Group Revenue, Net Income & 10-K Summary

Corporate history

Incorporated in Nevada on October 30, 2013 as Bling Marketing, Inc. (BMI).
Operated a jewelry wholesale business through June 2014; recorded $22,025 in sales for the three months ended June 30, 2014.
Began distributing jewelry through multiple distributors in 2014.
On December 29, 2014, completed a reverse merger with NuGene Inc.; NuGene was the accounting acquirer and BMI the accounting acquiree.
In 2014 issued 26,052,760 shares of BMI common stock and 1,917,720 shares of a new Series A Preferred Stock to NuGene shareholders.
Authorized a 15.04-to-1 stock split via a stock dividend in December 2014.
December 29, 2014 stock placement sold 2,000,000 shares for total proceeds of $2,000,000 (cash $1,625,000 and $375,000 in promissory notes).
Through 2017 the NuGene line transitioned toward cosmeceutical skincare; by year-end 2014 approximately 50 locations sold NuGene products.
In 2017 the NuGene cosmeceutical business was discontinued and the Nevada corporate charter was revoked.

January 26, 2020: Emergent, LLC, controlled by Milan I. Hoffman, was appointed custodian to revive the company and address indebtedness.
March 2022: Hoffman sold Series A Preferred stock; David Stybr (CEO of Livento Group) contributed Livento Group, LLC to the company in exchange for 5,000,000 shares of Series C Preferred.
Since 2022 the company’s operations have been those of Livento Group, LLC.

Delaware subsidiary formed June 17, 2022; wholly owned by the company. BOXO holds the company’s film-related assets.
Operates with a production team and contractors; BOXO itself did not maintain direct employees at the time described.
Production activity in 2022 included pursuit of up to 6 movies and 12 television productions and projects already in development or post-production.
Production slate and activity:
- Productions started in 2022: Carnival of Killers, Wash Me in the River, Running Wild.
- Wash Me in the River released in Q4 2022.
- Two additional films expected to move to development/production in 2023 with filming/postproduction completion targeted in 2024.
- The production team includes three long-time consultants with experience on approximately 300 movie projects; they serve as producers, executive producers and agents.
Revenue model: BOXO negotiates distribution agreements; distributors provide advance payments and BOXO participates in box office and home sales revenue.
May 26, 2023: Boxo Productions acquired interests in 45 projects from Loredo LLC valued at $22,320,641 in exchange for 391,590,193 shares of common stock.

Boxo Technology entered agreements with West East Wind Limited (WEWL) to acquire gaming app rights and to transfer interests in two real estate projects (Thunder and Geminos) not pursued.
WEWL assets were valued at $9,929,359; Boxo Technology acquired rights to three gaming apps in the May 26, 2023 transaction.

Originated in 2017 as an internal team developing AI-based financial management software for investment entities.
Product: Elisee — a data analytics and software system that captures large data sets, performs predictive asset and portfolio analyses, and provides portfolio recommendations.
Data and methods: acquires data from Dow Jones and other public sources; uses neural network algorithms and portfolio diversification logic; handles covariance and correlation in risk-aware asset selection.
Capabilities: processes up to 1 TB of data in one hour.
Staff: 11 employees and consultants total — 3 developers for Elisee, 3 in Financial Management, 2 administrative staff, and remaining roles in management.
Marketing and go-to-market strategy: social media, PR and video communications, and direct, personal outreach; positions Elisee as a diversification tool for portfolio construction.

2020 Prague suburb land acquisition: $4,000,000 purchase for a planned 16-unit residential condominium development; completion targeted for late 2022.
Associated purchase agreements totaling $12,000,000; estimated development cost around $3,000,000; projected gross profit approximately $5,000,000 (excluding carrying costs).
One additional real estate project received approximately $825,000 of investment and was under discussion for sale by the end of 2022.
The company stated it does not plan further real estate development opportunities.

Geographic presence: BOXO activities located in New York City and Prague, with virtual and remote operations and use of serviced-office space.
Headcount: 11 total employees and consultants across the company; BOXO relies on production consultants and contracted staff rather than direct employees.
Competitive positioning:
- BOXO competes with other production companies and streaming platforms and differentiates through access to experienced industry talent and a track record in targeted market segments.
- Elisee competes with other data analytics and portfolio construction tools and differentiates by predictive portfolio capabilities and neural-network-based analysis.

One active civil lawsuit in California alleging failure to pay for services. The company disputes the claim and is defending the matter with counsel.

2014: BMI revenue for the three months ended June 30, 2014 — $22,025.
December 29, 2014 stock placement proceeds — $1,625,000 cash and $375,000 in promissory notes (total $2,000,000).
2014: NuGene Line sold in about 50 locations by year-end 2014.
December 2014 stock split: 15.04-to-1 effect via stock dividend.
2014 securities issued to NuGene shareholders: 26,052,760 common shares and 1,917,720 Series A Preferred shares.
May 26, 2023: Boxo Productions acquisition from Loredo LLC — $22,320,641 in interests in 45 projects for 391,590,193 common shares.
May 26, 2023: WEWL assets valued at $9,929,359 related to Boxo Technology transactions.
2020 Prague real estate: $4,000,000 land purchase; $12,000,000 in purchase agreements; $3,000,000 estimated development cost; target completion 2022; expected gross profit approximately $5,000,000.